David Young
Founder chez PROCESSA PHARMACEUTICALS, INC.
Fortune : 239 357 $ au 31/03/2024
Profil
David Young was the founder of GloboMax LLC, founded in 2003, where he served as the Chief Executive Officer.
He is also the founder of Processa Pharmaceuticals, Inc., founded in 2011, where he currently holds the title of Director and President-Research & Development.
Dr. Young is also the founder of Promet Therapeutics LLC.
Dr. Young's former job positions include President & Executive Director at AGI Therapeutics Plc, Director, Chief Executive & Financial Officer at Heatwurx, Inc., Managing Director-Clinical Research Unit at the University of Maryland, President & Executive Director at AGI Therapeutics, Inc., Director-Pharmacokinetics & Associate Professor at the University of Maryland School of Pharmacy, and Chief Scientific Officer at Questcor Pharmaceuticals, Inc. from 2009 to 2014.
He also served as EVP-Strategic Drug Development Division at ICON plc from 1997 to 2003.
In terms of education, Dr. Young holds a doctorate degree from the University of Southern California, a graduate degree from the University of Wisconsin, and an undergraduate degree from the University of California, Berkeley.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
07/02/2024 | 101 208 ( 5,93% ) | 239 357 $ | 31/03/2024 |
Postes actifs de David Young
Sociétés | Poste | Début |
---|---|---|
PROCESSA PHARMACEUTICALS, INC. | Founder | 29/03/2011 |
Anciens postes connus de David Young
Sociétés | Poste | Fin |
---|---|---|
QUESTCOR PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | 01/01/2014 |
AGI Therapeutics, Inc. | President | - |
GloboMax LLC | Chief Executive Officer | - |
ICON PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | President | - |
Formation de David Young
University of Southern California | Doctorate Degree |
University of Wisconsin | Graduate Degree |
University of California, Berkeley | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
ICON PUBLIC LIMITED COMPANY | Commercial Services |
PROCESSA PHARMACEUTICALS, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
AGI Therapeutics Plc
AGI Therapeutics Plc Pharmaceuticals: MajorHealth Technology AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland. | Health Technology |
Heatwurx, Inc.
Heatwurx, Inc. Trucks/Construction/Farm MachineryProducer Manufacturing Heatwurx, Inc. engages in the development and sale of asphalt and pavement repair equipment. The company was founded by Larry C. Griffin and David J. Eastman on March 29, 2011 and is headquartered in Gardena, CA. | Producer Manufacturing |
AGI Therapeutics, Inc. | |
GloboMax LLC | |
Promet Therapeutics LLC
Promet Therapeutics LLC Pharmaceuticals: MajorHealth Technology Promet Therapeutics LLC engage in the clinical stage biotechnology company that develops drug products to treat patients who have suboptimal or no treatment alternatives. The company was founded on September 16, 2015 and is headquartered in Ellicott City, MD. | Health Technology |